Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement.
暂无分享,去创建一个
Isabel Freitas | Sergio Barni | S. Barni | I. Freitas | G. Baronzio | E. Boncompagni | Eleonora Boncompagni | Carla Fenoglio | Rita Vaccarone | Gian Franco Baronzio | R. Vaccarone | C. Fenoglio
[1] Weinberg Ed. The role of iron in cancer. , 1996 .
[2] A. Harris,et al. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. , 2006, Cancer Research.
[3] M. Bissell,et al. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.
[4] G. Chiesa,et al. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. , 2000, Cancer research.
[5] M. Hentze,et al. Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.
[6] D. Richardson,et al. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.
[7] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[8] D. Richardson,et al. Competing pathways of iron chelation: Angiogenesis or anti‐tumor activity: Targeting different molecules to induce specific effects , 2004, International journal of cancer.
[9] D. Richardson,et al. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics , 2006, Proceedings of the National Academy of Sciences.
[10] D. Richardson,et al. The role of iron in cell cycle progression and the proliferation of neoplastic cells. , 2002, Biochimica et biophysica acta.
[11] R K Jain,et al. Transport of molecules, particles, and cells in solid tumors. , 1999, Annual review of biomedical engineering.
[12] A. Pearse. Histochemistry: Theoretical and Applied , 1953 .
[13] Maria Grazia Sacco,et al. Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice. , 2003, Anticancer research.
[14] M. Gassmann,et al. Regulating cellular oxygen sensing by hydroxylation. , 2006, Cardiovascular research.
[15] S. Spicer,et al. FERRITIN PARTICLES IN MACROPHAGES AND IN ASSOCIATED MAST CELLS , 1972, The Journal of cell biology.
[16] T. Ganz,et al. Regulation of iron acquisition and iron distribution in mammals. , 2006, Biochimica et biophysica acta.
[17] D. Richardson. Therapeutic potential of iron chelators in cancer therapy. , 2002, Advances in experimental medicine and biology.
[18] B. L. O’dell. Roles for iron and copper in connective tissue biosynthesis. , 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[19] P. Gullino,et al. THE INTERSTITIAL FLUID OF SOLID TUMORS. , 1964, Cancer research.
[20] E. Weinberg. Iron Withholding as a Defense Strategy , 2005 .
[21] A. H. Baggenstoss,et al. Iron-storage diseases. , 1955, American journal of clinical pathology.
[22] V. Bertone,et al. Stroma formation in Ehrlich carcinoma. I. Oedema phase. A mitosis burst as an index of physiological reoxygenation? , 1991, Anticancer research.
[23] E. Brunt,et al. Pathology of Hepatic Iron Overload , 2005, Seminars in liver disease.
[24] V. Bertone,et al. Tumor interstitial fluid: misconsidered component of the internal milieu of a solid tumor. , 1997, Anticancer research.
[25] J. Brock. The physiology of lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[26] D. Richardson. Iron and neoplasia: serum transferrin receptor and ferritin in prostate cancer. , 2004, Journal of Laboratory and Clinical Medicine.
[27] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[28] E. D. Hager,et al. Hyperthermia in Cancer Treatment: A Primer , 2006 .
[29] K. Sandelin,et al. Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment , 2004, Molecular & Cellular Proteomics.
[30] F. A. Hoffman. Metabolic Changes in Malignancy , 1989 .
[31] F. Torti,et al. The role of iron chelation in cancer therapy. , 2003, Current medicinal chemistry.